TSR INC (TSRI) Fundamental Analysis & Valuation

NASDAQ:TSRI • US8728852075

Current stock price

13.38 USD
+0.01 (+0.04%)
At close:
13.3584 USD
-0.02 (-0.16%)
After Hours:

This TSRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TSRI Profitability Analysis

1.1 Basic Checks

  • TSRI had positive earnings in the past year.
  • In the past year TSRI had a positive cash flow from operations.
  • In multiple years TSRI reported negative net income over the last 5 years.
  • In multiple years TSRI reported negative operating cash flow during the last 5 years.
TSRI Yearly Net Income VS EBIT VS OCF VS FCFTSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

  • TSRI has a Return On Assets of 7.75%. This is in the better half of the industry: TSRI outperforms 76.83% of its industry peers.
  • TSRI has a better Return On Equity (10.80%) than 71.95% of its industry peers.
  • With a decent Return On Invested Capital value of 7.89%, TSRI is doing good in the industry, outperforming 68.29% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for TSRI is significantly below the industry average of 11.08%.
  • The 3 year average ROIC (5.05%) for TSRI is below the current ROIC(7.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROIC 7.89%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
TSRI Yearly ROA, ROE, ROICTSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

  • The Profit Margin of TSRI (2.15%) is comparable to the rest of the industry.
  • TSRI's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 2.34%, TSRI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • TSRI's Operating Margin has improved in the last couple of years.
  • TSRI's Gross Margin of 17.57% is on the low side compared to the rest of the industry. TSRI is outperformed by 92.68% of its industry peers.
  • In the last couple of years the Gross Margin of TSRI has grown nicely.
Industry RankSector Rank
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
TSRI Yearly Profit, Operating, Gross MarginsTSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

9

2. TSRI Health Analysis

2.1 Basic Checks

  • TSRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TSRI has less shares outstanding than it did 1 year ago.
  • TSRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TSRI Yearly Shares OutstandingTSRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
TSRI Yearly Total Debt VS Total AssetsTSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 8.47 indicates that TSRI is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.47, TSRI belongs to the best of the industry, outperforming 90.24% of the companies in the same industry.
  • TSRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.47
ROIC/WACC0.77
WACC10.19%
TSRI Yearly LT Debt VS Equity VS FCFTSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that TSRI has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.37, TSRI belongs to the best of the industry, outperforming 81.71% of the companies in the same industry.
  • TSRI has a Quick Ratio of 3.37. This indicates that TSRI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.37, TSRI belongs to the best of the industry, outperforming 81.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
TSRI Yearly Current Assets VS Current LiabilitesTSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

4

3. TSRI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.48% over the past year.
  • The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
  • Looking at the last year, TSRI shows a very negative growth in Revenue. The Revenue has decreased by -13.51% in the last year.
  • The Revenue has been growing by 9.30% on average over the past years. This is quite good.
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TSRI Yearly Revenue VS EstimatesTSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

4. TSRI Valuation Analysis

4.1 Price/Earnings Ratio

  • TSRI is valuated correctly with a Price/Earnings ratio of 15.56.
  • Compared to the rest of the industry, the Price/Earnings ratio of TSRI indicates a somewhat cheap valuation: TSRI is cheaper than 75.61% of the companies listed in the same industry.
  • TSRI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.88.
Industry RankSector Rank
PE 15.56
Fwd PE N/A
TSRI Price Earnings VS Forward Price EarningsTSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TSRI indicates a rather cheap valuation: TSRI is cheaper than 84.15% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, TSRI is valued cheaper than 84.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 7.99
TSRI Per share dataTSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2YN/A
EPS Next 3YN/A

0

5. TSRI Dividend Analysis

5.1 Amount

  • TSRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TSRI Fundamentals: All Metrics, Ratios and Statistics

TSR INC

NASDAQ:TSRI (6/28/2024, 8:00:01 PM)

After market: 13.3584 -0.02 (-0.16%)

13.38

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-10
Earnings (Next)08-09
Inst Owners6.6%
Inst Owner Change-43.85%
Ins Owners38.36%
Ins Owner Change0%
Market Cap29.03M
Revenue(TTM)88.82M
Net Income(TTM)1.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE N/A
P/S 0.33
P/FCF 13.32
P/OCF 13.32
P/B 1.64
P/tB 1.85
EV/EBITDA 7.99
EPS(TTM)0.86
EY6.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1
FCFY7.51%
OCF(TTM)1
OCFY7.51%
SpS40.93
BVpS8.15
TBVpS7.23
PEG (NY)N/A
PEG (5Y)0.63
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROCE 11.4%
ROIC 7.89%
ROICexc 19.04%
ROICexgc 25.92%
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
FCFM 2.46%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
ROICexc(3y)9.78%
ROICexc(5y)N/A
ROICexgc(3y)13.54%
ROICexgc(5y)N/A
ROCE(3y)7.31%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y1.93%
ROICexc growth 3YN/A
ROICexc growth 5Y-3.61%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
F-Score8
Asset Turnover3.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 114.1%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 8.47
F-Score8
WACC10.19%
ROIC/WACC0.77
Cap/Depr(3y)40.97%
Cap/Depr(5y)64.58%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.3%
EBIT growth 3YN/A
EBIT growth 5Y24.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.24%
FCF growth 3YN/A
FCF growth 5Y9.41%
OCF growth 1Y229.8%
OCF growth 3YN/A
OCF growth 5Y9.14%

TSR INC / TSRI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TSR INC?

ChartMill assigns a fundamental rating of 5 / 10 to TSRI.


What is the valuation status of TSR INC (TSRI) stock?

ChartMill assigns a valuation rating of 4 / 10 to TSR INC (TSRI). This can be considered as Fairly Valued.


What is the profitability of TSRI stock?

TSR INC (TSRI) has a profitability rating of 5 / 10.


What is the valuation of TSR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TSR INC (TSRI) is 15.56 and the Price/Book (PB) ratio is 1.64.


How financially healthy is TSR INC?

The financial health rating of TSR INC (TSRI) is 9 / 10.